1 - 25 of 22
Number of results to display per page
TitleCreatorDate
1 Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control CohortRachel Kenney; Mengling Liu; Lisena Hasanaj; Binu Joseph; Abdullah A. Al-Hassan; Lisanne Balk; Raed Behbehani; Alexander U. Brandt; Peter A. Calabresi; Elliot M. Frohman; Teresa Frohman; Joachim Havla; Bernhard Hemmer; Hong Jiang; Benjamin Knier; Thomas Korn; Letizia Leocani; Elena H. Martínez-Lapi...2022-12
2 Internuclear Ophthalmoplegia Characterizes Multiple Sclerosis Rather Than Neuromyelitis Optica Spectrum DiseaseMahmoud M. Hamza; Basheer F. Alas; Connie Huang; Justin C. Quon; Lilyana Amezcua; Michael V. Robers; Kimberly K. Gokoffski2022-06
3 Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple SclerosisS. Dreyer-Alster; A. Gal; A. Achiron2022-03
4 Bruch Membrane Opening Minimum Rim Width in Neuromyelitis OpticaLorane Bechet, MD; Philippe Cabre, MD, PhD; Harold Merle, MD, PhD2022-03
5 Is Neuroretinitis Associated With Multiple Sclerosis?N. R. Miller; L. N. Johnson; T. Bakaeva; G. P. Van Stavern; A. G. Lee2022-03
6 Papilledema in a Patient Being Treated for Multiple SclerosisLarry Frohman, MD; Roger E. Turbin, MD; Peter J. Wawrzusin, MD; Gaurav Srivastava, MD; Nicole M. Sakla, DO2021-12
7 Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple SclerosisAmy T. Waldman, MD, MSCE; Leslie Benson, MD; John R. Sollee, BS; Amy M. Lavery, PhD; Geraldine W. Liu, ALM; Ari J. Green, MD, MCR; Emmanuelle Waubant, MD; Gena Heidary, MD, PhD; Darrel Conger, CRA; Jennifer Graves, MD, PhD; Benjamin Greenberg, MD, MHS2021-12
8 Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple SclerosisMaria Cellerino; Luca Priano; Nicolò Bruschi; Giacomo Boffa; Maria Petracca; Giovanni Novi; Caterina Lapucci; Elvira Sbragia; Antonio Uccelli; Matilde Inglese2021-09
9 Shortened Pattern Electroretinogram Latency and Impaired Autoregulatory Dynamics to Steady-State Stimuli in Patients With Multiple SclerosisHong Jiang; Giovana R. Gameiro; Huiling Hu; Pedro F. Monsalve; Chuanchui Dong; Jeffrey Hernandez; Silvia R. Delgado; Vittorio D. Porciatti; Jianhua Wang2021-03
10 Glial Fibrillary Acidic Protein Antibody - Another Antibody in the Multiple Sclerosis Diagnostic MixMeagan Seay, DO; Steven Galetta, MD2018-09
11 Multiple Sclerosis: B Cells Take Center StageAnne-Katrin Pröbstel, MD; Stephen L. Hauser, MD2018-06
12 Multiple Sclerosis Therapy: Are We Ready for a One-Size-Fits-All Approach?Bruce A. C. Cree, MD, PhD, MAS2018-06
13 Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying TherapiesRachel C. Nolan, BA; Omar Akhand, BS; John-Ross Rizzo, MD, MSCI; Steven L. Galetta, MD; Laura J. Balcer, MD, MSCE2018-06
14 New Ways of 'Seeing' the Mechanistic Heterogeneity of Multiple Sclerosis Plaque PathogenesisEthan I. Meltzer; Fiona E. Costello; Elliot M. Frohman; Teresa C. Frohman2018-03
15 Multiple Sclerosis: Eyes on the FutureFiona E. Costello, MD, FRCPC; Jodie M. Burton, MD, MSc, FRCPC2018-03
16 Keep Your Eyes Wide Open: On Visual- and Vision-Related Measurements to Better Understand Multiple Sclerosis PathophysiologyYael Backner, Msc; Netta Levin, MD, PhD2018-03
17 Ocular Motor Manifestations of Multiple SclerosisElodie Nerrant, MD; Caroline Tilikete, MD, PhD2017-09
18 Is Multiple Sclerosis Associated With a Lower Intraocular Pressure?Norah S. Lincoff, MD; Andrea Buccilli, MD; Bianca Weinstock-Guttman, MD; Sandra Sieminski, MD; Sirin Gandhi, MD2017-09
19 Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?: CommentPrem S. Subramanian; Jiawei Zhao; Sarita B. Davé; Jiangxia Wang'2017-03
20 Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?: Response.Helena Felgueiras; Joana Parra; Simão Cruz; Pedro Pereira; Ana F. Santos; Adriana Rua; Dália Meira; Pedro Fonseca; Catarina Pedrosa; João N. Cardosa; Cristina Almeida; Maria Araújo; Ernestina Santos2017-03
21 Strabismus Surgery in Patients With Ocular Neuromyotonia: Potential Unmasking of the Condition and Effective Management ToolJ. Anna Kim, MD; Federico G. Velez, MD; Stacy L. Pineles, MD2016-09
22 Neuro-Ophthalmic Syndromes and Processing Speed in Multiple SclerosisSilvana L. Costa, PhD; Óscar F. Gonçalves, PhD; Nancy D. Chiaravalloti, PhD; John DeLuca, PhD; Jorge Almeida, PhD2016-03
1 - 25 of 22